Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 28998

AbstractMaterial and MethodsResultsDiscussionConclusionAcknowledgementReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2023 | Month : November | Volume : 17 | Issue : 11 | Page : CC09 - CC13 Full Version

Gender-wise Distribution of Cardiovascular Risk and Its Correlation with Dietary Intake, Physical Activity, and Perceived Stress: A Cross-sectional Study


Published: November 1, 2023 | DOI: https://doi.org/10.7860/JCDR/2023/64472.18721
Ambrin Zenab, Sudhanshu Kacker, Neha Saboo, Munesh Kumar

1. Postgraduate, Department of Physiology, RUHS College of Medical Sciences, Jaipur, Rajasthan, India. 2. Senior Professor, Department of Physiology, RUHS College of Medical Sciences, Jaipur, Rajasthan, India. 3. Associate Professor, Department of Physiology, RUHS College of Medical Sciences, Jaipur, Rajasthan, India. 4. Associate Professor, Department of Gastroenterology, RUHS College of Medical Sciences, Jaipur, Rajasthan, India.

Correspondence Address :
Dr. Neha Saboo,
Associate Professor, Department of Physiology, RUHS College of Medical Sciences, Jaipur-302033, Rajasthan, India.
E-mail: nehasaboo08@gmail.com

Abstract

Introduction: Cardiovascular Diseases (CVDs) are a group of disorders affecting the heart and blood vessels, including Coronary Heart Disease (CHD), cerebrovascular disease, rheumatic heart disease, peripheral artery disease, congenital heart disease, and pulmonary embolism. CVDs contribute to approximately 17.9 million deaths worldwide each year. Risk factors for CVDs can be classified as non modifiable (such as age, gender, ethnicity, and family history) and modifiable (such as obesity, dyslipidaemia, diabetes, hypertension, stress, poor diet, and physical inactivity). Men are more susceptible to CVDs than women. The QRISK3 risk score is an algorithm used to predict an individual’s 10 year risk of developing CVDs.

Aim: To assess the distribution of CVD risk among men and women aged 30-70 years using the QRISK3 risk score and its correlation with dietary intake, physical activity, and perceived stress.

Materials and Methods: A cross-sectional study was conducted at the Department of Physiology at RUHS-CMS and Associated Hospitals in Jaipur, Rajasthan, India. The study duration was six months, from July 2022 to December 2022. A total of 220 subjects, aged 30-70 years, of both sexes were recruited from the Outpatient Department (OPD) of Medicine, based on inclusion and exclusion criteria. The QRISK3 web calculator was used to calculate the CVD risk, which was then correlated with the Food Frequency Questionnaire (FFQ), Perceived Stress Scale (PSS), and Global Physical Activity Questionnaire (GPAQ). Statistical analysis was performed using the Chi-square test for qualitative analysis, and Pearson’s correlation analysis was used to assess correlations.

Results: The mean age of the study participants (males) was 42.75±10.86 years and (females) was 42.82±10.85 years. A total of 220 participants (123 males and 97 females) aged between 30-70 years were included in the study. Among the males, 90 (73.17%) had low CVD risk, 15 (12.19%) had moderate risk, and 18 (14.63%) had high risk. Among the females, 83 (85.57%) had low risk, 9 (9.28%) had moderate risk, and 5 (5.15%) had high risk. There was a significant association between the QRISK3 risk score and gender (χ2=6.14, df=218, p=0.04). Males showed a stronger association with the QRISK3 risk score compared to females within different age groups. Significant positive correlations were observed between the QRISK3 score and FFQ (r=0.28) and PSS (0.42). Additionally, a significant negative correlation was found between the QRISK3 score and GPAQ (-0.24).

Conclusion: The QRISK3 score calculator was found to be useful in assessing the 10-year risk of developing CVDs in males and females across different age groups. The association between CVD risk and various scores suggests that perceived stress is strongly correlated with CVD risk.

Keywords

Cardiovascular disease, Food frequency questionnaire, Risk factors, Rheumatic heart disease

Non Communicable Diseases (NCDs) are a broad category of chronic illnesses that cannot be spread. They are defined as diseases of long duration, generally slow progression, and are the major cause of adult mortality and morbidity worldwide (1). Approximately 41 million people die each year from NCDs worldwide, accounting for around 71% of all fatalities (2). NCDs also account for 48% of the healthy life years lost, known as Disability Adjusted Life Years (DALYs), worldwide (3). The major four NCDs are CVD, Chronic Respiratory Conditions (CRC), malignancies, and diabetes. Each year, approximately 17.9 million people die worldwide due to CVDs, followed by cancers (9.3 million) WHO, 2021 (4). The total number of CVD cases nearly doubled from 271 million in 1990 to 523 million in 2019, and CVD-related fatalities rose sharply from 12.1 million in 1990 to 18.6 million in 2019 (5).

The CVD risk factors are classified into two broad categories. non modifiable risk factors include age, gender, ethnicity, and family history of CVD. Modifiable risk factors include smoking, dyslipidaemia, diabetes, hypertension, abdominal obesity, lack of daily consumption of fruits and vegetables, lack of physical activity, regular alcohol consumption, and psychosocial factors (e.g., depression, perceived stress, and life events). The identification of modifiable risk factors suggests that aggressive risk factor adjustment in individuals at risk of acquiring the disease can prevent a significant number of CVD cases. Therefore, research has focused on identifying those at the highest risk of developing CVD for over 40 years, allowing effective prevention and treatment methods to be directed towards them (6).

Males are more likely than females to develop CHD and often experience CVD at a younger age. In contrast, women have a higher risk of developing a stroke, which often occurs as they age (7),(8). Women are comparatively protected against CVD before menopause (9). Premenopausal women have an overall reduced risk of CVD, which is typically attributed to the cardioprotective effects of oestrogen (9),(10),(11). As oestrogen levels gradually decrease after puberty, men are likely to experience heart disease 10 to 15 years earlier than women (12).

In contrast, males over 70 years have a decreased total CV risk compared to women aged 50 years, which is the usual age of menopause in women (13). The present finding strongly implies that the reduction of oestrogen affects CVD risks more in women than in men, with upto 2-4 times higher risk at the onset of menopause (14). Consequently, middle-aged men often have higher rates of stroke and CHD mortality than middle-aged women (15),(16).

Several CV risk scoring systems are currently available for different population groups, such as the Framingham Risk Score (RiskFRS) (17),(18), Prospective Cardiovascular Munster Score (PROCAM) (19), Systemic Coronary Risk Evaluation (SCORE) (20), World Health Organisation/International Society of Hypertension (WHO/ISH) risk prediction charts (RiskWHO) (21), the American College of Cardiology/American Heart Association (ACC/AHA) pooled cohort equations (RiskACC/AHA) (22), and the 3rd iteration of Joint British Societies’ risk calculator (RiskJBS) (23). These risk algorithms are based on epidemiological data and are applicable only to the populations from which the data was derived. Unfortunately, none of the currently available risk prediction models are based on Indian data, despite the inclusion of Indian ethnicity as a risk factor in the QRISK3 risk score.

In the present study, CV risk was assessed using the QRISK3 risk score, which takes into account the presence and severity of various major CVD risk factors. The QRISK3 prediction algorithm is used to estimate the 10-year risk of CVD in women and men (24). A 10 year risk of less than 10% is generally considered low risk, 10%-19% indicates intermediate risk, and 20% or higher indicates high risk.

The explosive increase in the prevalence of CVD is due to the adoption of unhealthy lifestyle practices by individuals who are at risk of developing the disease. Lack of physical activity, psychosocial factors (e.g., depression, perceived stress, and life events), and unhealthy diets have emerged as important modifiable risk factors not only for CVD but also for other chronic non communicable diseases like diabetes.

There are very few studies in India, that have reported the distribution of CVD risk in men and women and their correlation with dietary intake, perceived stress, and physical activity is lacking (25),(26). The rationale of the present study was to help identify CV risk and provide a strategy for physicians to intervene and treat high-risk individuals properly. The present study also raised the awareness among people about their CV risk score and CVD risk factors. Therefore, the present study was undertaken with the aim of analysing the gender-wise distribution of CVD risk among the 30-70 years age group population and its correlation with dietary intake, perceived stress, and physical activity. The objectives of the study were to determine the gender-wise distribution of CV risk factors among study participants, assess the correlation of QRISK3 risk score with GPAQ, PSS, and FFQ scores in male and female participants, and assess the correlation of QRISK3 risk score with GPAQ, PSS, and FFQ scores in the total study participants.

Material and Methods

A cross-sectional study was carried out in the Department of Physiology at RUHS-CMS and Associated Hospitals, Jaipur, Rajasthan, India. The study duration was six months, from July 2022 to December 2022. The study was done, after obtaining approval from the Institutional Ethics Committee (IEC/P-17/2022).

Inclusion criteria: Individuals between the ages of 30-70 years, of either sex, who provided written informed consent, and were attending the medicine OPD at RUHS-CMS and associated hospitals, Jaipur, were included in the study.

Exclusion criteria: Individuals with any previously diagnosed coronary artery disease, pregnant or nursing mothers, and individuals with mental illnesses (such as schizophrenia or bipolar disorder) were excluded from the study.

Sample size calculation: The sample size of 220 was calculated using the formula n=z2×p×q/e2, with a confidence interval of 95%, a margin of error of 5%, and a non response rate of 10%, based on the prevalence of 14.1% of CVD (27).

Study Procedure

After screening 1400 patients, a total of 220 individuals of both genders, aged 30-70 years, attending the medicine OPD, were recruited after providing prior information via the Patient Information Sheet (PIS) and obtaining written informed consent from them. Anthropometric data, including age, gender, height, weight, and waist/hip ratio, were recorded, and the Body Mass Index (BMI) was calculated. Each subject’s BMI was calculated as weight in kg divided by height in square meters (28). Sociodemographic variables such as geographic area, marital status, educational status, and socioeconomic status were also recorded (29). CVD family history and detailed medical history were collected. Dietary intake was assessed using the FFQ (30). The nutrient value of each food item was calculated using a scoring key (30). Perceived stress was assessed using the PSS (31). Individual scores on the PSS can range from 0 to 40, with higher scores indicating higher perceived stress. Scores ranging from 0-13 were considered as low stress, 14-26 as moderate stress, and 27-40 as high perceived stress (31). Physical activity was assessed using the GPAQ (32). According to WHO guidelines, physical activity was calculated in terms of a person’s overall energy expenditure {Metabolic Equivalent of Task (MET) minutes per week) using GPAQ data. The following MET values were used: <600 MET minutes/week - physically inactive, 600-1200 MET minutes/week - active, and >1200 MET minutes/week - highly active [32,33]. Blood pressure was recorded for all subjects in a sitting position on the right arm using a standard mercury sphygmomanometer. The mean and Standard Deviation (SD) of systolic blood pressure readings were taken into consideration. After an overnight fasting of 8-10 hours, venous blood samples (5 mL) were collected using aseptic technique and subjected to various routine laboratory investigations, such as total cholesterol, High-density Lipoprotein Cholesterol (HDLC), fasting blood glucose, and Glycated Haemoglobin (HbA1c).

The CVD risk was calculated for each subject using the QRISK3 web calculator, and subjects were categorised as low risk (<10%), moderate risk (10-20%), and high risk (>20%) individuals, according to their QRISK3 risk score (34).

Statistical Analysis

Statistical analysis was performed using International Business Machines (IBM) Statistical Package for Social Sciences (SPSS) version 21.0 software. The Kolmogorov-Smirnov test was conducted to test the normality of the variables. Mean and SD were calculated for individual quantitative parameters. Continuous variables were compared using Student’s t-test, while categorical variables were compared using the Chi-square test. A p-value <0.05 was considered statistically significant. Associations were assessed using Chi-square tests of association, and a p-value <0.05 was considered significant. Pearson’s correlation analysis was conducted to assess correlations.

Results

The study was conducted on 220 participants, of which 123 were males and 97 were females. (Table/Fig 1) shows that the mean age of males was 42.75±10.86 years and females was 42.82±10.85 years (p=0.96). The mean Body Mass Index (BMI) of males was 23.89±3.97 Kg/m2 and females was 22.69±3.96 Kg/m2, which is significantly higher in males than in females (p=0.02).

(Table/Fig 2) shows the distribution of study participants according to their sociodemographic variables. According to the geographic area, 68.6% of the people are from urban areas. A total of 77.3% of the study participants are married. According to educational status, 25.9% of the study participants have a middle school certificate. According to socioeconomic status, 41.4% of the participants are from the upper lower class. (Table/Fig 3) shows the distribution of CVD risk factors between males and females. The mean blood pressure was significantly higher in females (p=0.02). The mean Fasting Plasma Glucose (FPG) level of males was significantly higher (p=0.03) than in females. Significantly higher values of total cholesterol (p=0.03) and HDLC (p=0.008) were observed in females.

Mean FFQ score (p=0.04) and mean GPAQ score were (p<0.001) found to be significantly higher in males, whereas mean PSS score was significantly higher in females (p=0.006). (Table/Fig 4) shows the distribution of CV risk score (QRISK3 score) in males and females. Among the 123 males, 90 (73.17%) had low CVD risk, 15 (12.19%) had moderate risk, and 18 (14.63%) had high CVD risk. On the other hand, among the females, 83 (85.57%) had low, 9 (9.28%) had moderate, and 5 (5.15%) had high CVD risk. QRISK3 risk score is significantly associated with gender (χ2=6.14 df=218, p=0.04).

(Table/Fig 5) shows the distribution of CVD risk factors in men and women according to different age groups. Both males and females have a highly significant association with QRISK3 score categories; however, males are more significantly associated than females.

(Table/Fig 6) shows the age-wise comparison of CV risk between males and females. In the age group 30-40 years, there is no significant association of QRISK3 score categories between males and females (p=0.127), while in the age groups 41-50 years and 61-70 years, there is a significant association (p<0.05), and in the 51-60 years age group, a highly significant association was found (p<0.001).

(Table/Fig 7) shows the highly significant negative correlation between QRISK3 risk score and GPAQ score (p<0.001). There was a highly significant positive correlation observed between QRISK3 and PSS score (p<0.001). There was a weak significant positive correlation found between QRISK3 and FFQ score (p<0.001). PSS score is predominantly associated with increasing CVD risk.

(Table/Fig 8) shows the significant negative correlation between QRISK3 score and GPAQ score in both males (p<0.05) and females (p<0.05). A highly significant positive correlation was found between QRISK3 and Perceived Stress Scale (PSS) score in both males (<0.001) and females (<0.001). A highly significant positive correlation was found between QRISK3 and FFQ score in males (<0.001), and there was a weak significant positive correlation found between QRISK3 and FFQ score in females (p<0.05).

Discussion

The prevalence of CVD, including atherosclerosis, stroke, and myocardial infarction, has also been demonstrated to rise with aging in both men and women. CVD risks are increased by additional modifiable risk factors, such as obesity, dyslipidaemia, diabetes, hypertension, stress, poor diet, and inactivity. These factors are known to exacerbate and complicate cardiac risk factors linked to the onset of old age. In the present study, authors analysed the CVD risk profile in an outpatient setting in Jaipur, Rajasthan, India. There was no statistically significant difference found in the mean age of males and females in the present study. The mean BMI for males was significantly higher than for females (Table/Fig 1). These results were similar to a study done by Zhang J et al., which reported that men had a significantly higher mean BMI (34).

In the present study, a higher number of subjects were in the upper lower class (Table/Fig 2). Another study done by Pangtey R et al., reported that most of the population belongs to the upper-lower class, which is consistent with the results of the present study (35). The mean blood pressure was significantly higher in females compared to males. Mohanty P et al., also reported that males had a higher prevalence of hypertension up to 50 years, after which females had significantly higher rates, which is consistent with the results of the present study (36).

The mean FPG level was significantly higher in males (Table/Fig 3). These results were similar to a study conducted by Soeters MR et al., in which plasma glucose levels were significantly lower in women than in men, whereas FFA and lipolysis were significantly higher (37). In the present study, 12.7% of participants were prediabetic and 9.5% were diabetic, as measured by HbA1c levels according to American with Disabilities Act (ADA) criteria. There was no statistically significant difference in the mean HbA1c levels between males and females (Table/Fig 3), which is contrary to a study conducted by Ma Q et al., where HbA1c levels in the male group were significantly higher than those in the female group (38).

In the present study, mean total cholesterol levels and mean HDLC levels in females were significantly higher than in males in the present study (Table/Fig 3). These results were similar to a study conducted by Gupta R et al., (39). There was no significant difference found in the mean total cholesterol/HDLC ratio between males and females (Table/Fig 3). These results are contrary to a study conducted by Gupta R et al., in which there was a significantly higher total/HDLC ratio in males (39).

The observed FFQ score in the present study for males was significantly higher than for females (Table/Fig 3). Similar results were reported in a study done by Gray P et al., in which males had a significantly higher calorie intake than females (40). The present study also shows that the mean PSS score is significantly higher in females (Table/Fig 3). Similarly, Graves BS et al., found significant gender differences in perceived stress levels, with females reporting significantly higher total PSS levels (41). The GPAQ score was found to be significantly higher in males in the present study (Table/Fig 3), which is consistent with a study done by Carthy M et al., who observed gender differences in physical activity status (42).

The present study concludes that CV risk is significantly associated with gender (Table/Fig 4), and a higher proportion of males were in the high-risk category compared to females (Table/Fig 5). Similar results were observed in a study done by Mukhopadhay S et al., where high CVD risk was found to be significantly more common in males (43). Before menopause, women are relatively protected from CVD. Oestrogen plays a cardioprotective role and is directly associated with a lower incidence of CVD in premenopausal women. After menopause, the risk for cardiac disease greatly increases in women (37).

A significant negative correlation was found between the QRISK3 score and the GPAQ score in the present study. A study conducted by Rasiah R et al., showed a statistically significant inverse relationship between physical activity and cumulative CVD risk factors. These findings are consistent with the present study (44). The correlation of the QRISK3 risk score with the PSS score was significantly positive in the present study. Similarly, Santosa A et al., found a positive correlation between psychological stress and the risk of CVD (45). The present study also shows a weak positive correlation between the QRISK3 score and the FFQ score, which is supported by another study done by McKeown NM et al., (Table/Fig 7) (46).

Limitation(s)

Data should have been obtained from different centres to obtain more reliable results. Additionally, comparing the data of the QRISK3 score with other validated CV risk scores would provide more convincing results in this regard.

Conclusion

The QRISK3 risk score takes into consideration many CVD risk factors, including Indian ethnicity. In addition to the classical CVD risk factors, QRISK3 also includes chronic kidney disease, migraine, the presence of inflammatory diseases such as rheumatoid arthritis and systemic lupus erythematosus, the use of atypical antipsychotics, and erectile dysfunction. Based on the findings of the present study, QRISK3 can be employed as a screening tool to identify individuals at high risk for CVD at early stages. This would allow for better education and the development of appropriate treatment strategies.

Acknowledgement

The authors would like to thank the staff of Department of Physiology and Medicine, RUHS College of Medical Sciences and associated hospitals, Jaipur, Rajasthan, India.

References

1.
World Health Organization. Preventing chronic diseases: A vital investment: WHO global report 2005. World Health Organization. [Online]. Available from: https://apps.who.int/iris/handle/10665/43314.
2.
World Health Organization. Noncommunicable diseases [Internet]. [cited 2018 June 1].
3.
Bloom DE, Cafiero ET, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima S, et al. The Global Economic Burden of Noncommunicable Diseases. Geneva: World Economic Forum; 2011.
4.
World Health Organization. Noncommunicable Diseases [Internet]. [cited 2021 Sep 2].
5.
Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: Update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982-3021. [crossref][PubMed]
6.
Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003;290(7):898-904. [crossref][PubMed]
7.
George J, Rapsomaniki E, Pujades-Rodriguez M, Shah AD, Denaxas S, Herrett E, et al. How does cardiovascular disease first present in women and men? Incidence of 12 cardiovascular diseases in a contemporary cohort of 1,937,360 people. Circulation. 2015;132(14):1320-28. [crossref][PubMed]
8.
Leening MJG, Ferket BS, Steyerberg EW, Kavousi M, Deckers JW, Nieboer D, et al. Sex differences in lifetime risk and first manifestation of cardiovascular disease: Prospective population based cohort study. BMJ. 2014;349:g5992. [crossref][PubMed]
9.
Villa A, Rizzi N, Vegeto E, Ciana P, Maggi A. Estrogen accelerates the resolution of inflammation in macrophagic cells. Sci Rep. 2015;5:15224. [crossref][PubMed]
10.
Iorga A, Cunningham CM, Moazeni S, Ruffenach G, Umar S, Eghbali M, et al. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ. 2017;8(1):33. [crossref][PubMed]
11.
Xue B, Singh M, Guo F, Hay M, Johnson AK. Protective actions of estrogen on angiotensin II-induced hypertension: Role of central nitric oxide. Am J Physiol Heart Circ Physiol. 2009;297(5):1638-46. [crossref][PubMed]
12.
Baker L, Meldrum KK, Wang M, Sankula R, Vanam R, Raiesdana A, et al. The role of estrogen in cardiovascular disease. J Surg Res. 2003;115(2):325-44. [crossref][PubMed]
13.
Lloyd-Jones DM, Leip EP, Larson MG, D’Agostino RB, Beiser A, Wilson PW, et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation. 2006;113(6):791-98. [crossref][PubMed]
14.
Costello BT, Sprung K, Coulter SA. The rise and fall of estrogen therapy: Is testosterone for “manopause” next? Tex Heart Inst J. 2017;44(5):338-40. [crossref][PubMed]
15.
Ali MK, Jaacks LM, Kowalski AJ, Siegel KR, Ezzati M. Non communicable diseases: Three decades of global data show a mixture of increases and decreases in mortality rates. Health Aff. 2015;34(9):1444-55. [crossref][PubMed]
16.
Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics-2015 update: A report from the American Heart Association. Circulation. 2015;131(4):e29-322.
17.
Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837-47. [crossref][PubMed]
18.
D’Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: The Framingham heart study. Circulation. 2008;117(6):743-53. [crossref][PubMed]
19.
Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation. 2002;105(3):310-15. [crossref][PubMed]
20.
Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al; SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project. Eur Heart J. 2003;24(11):987-1003. [crossref][PubMed]
21.
World Health Organization. Prevention of Cardiovascular Disease Guidelines for Assessment and Management of Cardiovascular Risk. Geneva: WHO; 2007.
22.
Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB, Gibbons R, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S49-73. [crossref][PubMed]
23.
JBS3 Board. Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3). Heart. 2014;100(Suppl 2):ii1-ii67. [crossref]
24.
Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: Prospective cohort study. BMJ. 2017;357:j2099. [crossref][PubMed]
25.
Unnikrishnan AG, Sahay RK, Phadke U, Sharma SK, Shah P, Shukla R, et al. Cardiovascular risk in newly diagnosed type 2 diabetes patients in India. PLoS ONE. 2022;17(3):e0263619. [crossref][PubMed]
26.
Ghosal S, Sinha B, Ved J, Biswas M. Quantitative measure of asymptomatic cardiovascular disease risk in Type 2 diabetes: Evidence from Indian outpatient setting. Indian Heart J. 2020;72(2):119-22. [crossref][PubMed]
27.
India State-Level Disease Burden Initiative CVD Collaborators. The changing patterns of cardiovascular diseases and their risk factors in the states of India: The Global Burden of Disease Study 1990-2016. Lancet Glob Health. 2018;6(12):e1339-51.
28.
National Health and Nutrition Examination Survey (NHANES)- Anthropometry Procedure Manual, January 2016. CDC; World Health Organization.
29.
Kuppuswamy B. Manual of socio-economic status scale (urban). Delhi; Manasyan; 1981;66-72.
30.
Telles S, Bhardwaj A, Gupta R, Kumar A, Balkrishna A. Development of a food frequency questionnaire to assess dietary intake for the residents of the northern region of India. Indian Journal to Ancient Medicine and Yoga. 2016;9(4):139-47. [crossref]
31.
Cohen S, Williamson G. Perceived stress in a probability sample of the United States. The Social Psychology of Health. 1988;31-67.
32.
World Health Organization. Surveillance and Population-Based Prevention, Prevention of Noncommunicable Diseases Department. 20 Avenue Appia, 1211 Geneva 27, Switzerland. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706262/
33.
Mu X, Wu A, Hu H, Zhou H, Yang M. Assessment of QRISK3 as a predictor of cardiovascular disease events in type 2 diabetes mellitus. Front Endocrinol (Lausanne). 2022;13:1077632. [crossref][PubMed]
34.
Zhang J, Xu L, Li J, Sun L, Qin W, Ding G, et al. Gender differences in the association between body mass index and health-related quality of life among adults: A cross-sectional study in Shandong, China. BMC Public Health. 2019;19(1):1021. [crossref][PubMed]
35.
Pangtey R, Basu S, Meena GS, Banerjee B. Perceived stress and its epidemiological and behavioral correlates in an urban area of Delhi, India: A community-based cross-sectional study. Indian J Psychol Med. 2020;42(1):80-86. [crossref][PubMed]
36.
Mohanty P, Patnaik L, Nayak G, Dutta A. Gender difference in prevalence of hypertension among Indians across various age-groups: A report from multiple nationally representative samples. BMC Public Health. 2022;22(1):1524. [crossref][PubMed]
37.
Soeters MR, Sauerwein HP, Groener JE, Aerts JM, Ackermans MT, Glatz JFC, et al. Gender-related differences in the metabolic response to fasting. J Clin Endocrinol Metab. 2007;92(9):3646-52. [crossref][PubMed]
38.
Ma Q, Liu H, Xiang G, Shan W, Xing W. Association between glycated hemoglobin A1c levels with age and gender in Chinese adults with no prior diagnosis of diabetes mellitus. Biomed Rep. 2016;4(6):737-40. [crossref][PubMed]
39.
Gupta R, Sharma M, Goyal NK, Bansal P, Lodha S, Sharma KK. Gender differences in 7 years trends in cholesterol lipoproteins and lipids in India: Insights from a hospital database. Indian J Endocrinol Metab. 2016;20(2):211-18. [crossref][PubMed]
40.
Gray P, Olendzki B, Kane K, Churchill L, Hayes RB, Aguirre A, et al. Comparison of dietary quality assessment using food frequency questionnaire and 24-hour-recalls in older men and women. AIMS Public Health. 2017;4(4):326-46. [crossref][PubMed]
41.
Graves BS, Hall ME, Dias-Karch C, Haischer MH, Apter C. Gender differences in perceived stress and coping among college students. PLoS One. 2021;16(8):e0255634. [crossref][PubMed]
42.
McCarthy C, Warne JP. Gender differences in physical activity status and knowledge of Irish University staff and students. Sport Sci Health. 2022;18(2):1283-91. [crossref]
43.
Mukhopadhay S, Mukherjee A, Khanra D, Samanta B, Karak A, Guha S. Cardiovascular risk in newly diagnosed type 2 diabetes patients in India. Egypt Heart J. 2021;73(1):94. [crossref][PubMed]
44.
Rasiah R, Thangiah G, Yusoff K, Manikam R, Chandrasekaran SK, Mustafa R, et al. The impact of physical activity on cumulative cardiovascular disease risk factors among Malaysian adults. BMC Public Health. 2015;15:1242. [crossref][PubMed]
45.
Santosa A, Rosengren A, Ramasundarahettige C, Rangarajan S, Gulec S, Chifamba J, et al. Psychosocial risk factors and cardiovascular disease and death in a population-based cohort from 21 low-, middle-, and high-income countries. JAMA Netw Open. 2021;4(12):e2138920. [crossref][PubMed]
46.
McKeown NM, Meigs JB, Liu S, Rogers G, Yoshida M, Saltzman E, et al. Dietary carbohydrates and cardiovascular disease risk factors in the Framingham offspring cohort. J Am Coll Nutr. 2009;28(2):150-58.[crossref][PubMed]

DOI and Others

DOI: 10.7860/JCDR/2023/64472.18721

Date of Submission: Apr 05, 2023
Date of Peer Review: Jul 13, 2023
Date of Acceptance: Sep 18, 2023
Date of Publishing: Nov 01, 2023

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. NA

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Apr 11, 2023
• Manual Googling: Aug 18, 2023
• iThenticate Software: Sep 16, 2023 (18%)

ETYMOLOGY: Author Origin

EMENDATIONS: 7

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com